Business
business

Nvidia poured $1 billion into AI companies in 2024 to try to make its customers more diversified

2024 was an huge year for Nvidia. It passed $3 trillion in valuation to become the biggest company in the world, and continued to beat earnings expectations. The company’s Hopper GPUs have fueled the AI boom, and the biggest companies are spending billions to hoard the powerful hardware. But Nvidia has also had a record year investing in many of its customers.

According to the FT, Nvidia invested a total of $1 billion in AI companies in 2024. The company is spending some of its $9 billion in cash to help diversify and grow the AI industry. But Nvidia is also hedging its bets as its current white-hot streak isn’t assured to last forever. Customers like Amazon, Meta, and Google are all working on their own AI chips, and there are signs that the current strategy of building bigger and bigger AI training clusters may be delivering diminished returns.

Having a robust portfolio of AI investments with rapidly growing valuations could provide a cushion if demand for Nvidia GPUs slackens.

But federal regulators will be keeping an eye on these deals, as Nvidia’s powerful position at the center of the industry could raise competition issues.

According to the FT, Nvidia invested a total of $1 billion in AI companies in 2024. The company is spending some of its $9 billion in cash to help diversify and grow the AI industry. But Nvidia is also hedging its bets as its current white-hot streak isn’t assured to last forever. Customers like Amazon, Meta, and Google are all working on their own AI chips, and there are signs that the current strategy of building bigger and bigger AI training clusters may be delivering diminished returns.

Having a robust portfolio of AI investments with rapidly growing valuations could provide a cushion if demand for Nvidia GPUs slackens.

But federal regulators will be keeping an eye on these deals, as Nvidia’s powerful position at the center of the industry could raise competition issues.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.